The FDA has approved Wegovy (semaglutide) tablets, the first oral GLP-1 receptor agonist for the treatment of obesity.

Among women with gestational diabetes, the use of real-time continuous glucose monitoring (rt-CGM) is associated with a lower incidence of large-for-gestational-age (LGA) infants and reduced ...

Withdrawal of tirzepatide treatment in adults with obesity who have achieved initial weight loss is associated with substantial weight regain and a corresponding reversal of the positive ...

Topline data were announced from a phase 3 trial evaluating ersodetug in patients aged 3 months to 45 years with congenital hyperinsulinism.

Higher body dissatisfaction was linked to more severe eating disorder, depressive symptoms in monozygotic and dizygotic twin difference analyses. HealthDay News — Body dissatisfaction may causally ...

The progression to T2D or cancer and the probability of death following prediabetes diagnosis vary according to age at prediabetes diagnosis, with most younger individuals remaining in the prediabetes ...

Five diabetes subgroups possess specific comorbidity risk profiles, with SIRD and SIDD generally exhibiting the highest risks for kidney disease, myocardial infarction, and total mortality compared ...

Credit: Getty Images The WHO released a guideline on the use of GLP-1 therapies for the treatment of obesity among adults. The World Health Organization (WHO) has released an evidence-informed ...

Higher consumption of proinflammatory or hyperinsulinemic diets is associated with an increased risk for T2D and unfavorable cardiometabolic profiles among women with a history of gestational diabetes ...

The FDA has linked the issue to 7 deaths and more than 700 serious injuries worldwide. HealthDay News — Millions of people rely on continuous glucose monitors to help manage diabetes. But a new alert ...

Women with prepregnancy obesity are more likely to have children with neurodevelopmental disabilities, specifically showing greater risks for epilepsy and intellectual disability. Women with ...